Cancer cells seem to sometimes use endoglin and ALK1 to trap BMP-9 protein: sENG binds to BMP-9 with high affinity and thereby blocks the type II receptor binding site on BMP-9, resulting in ALK1-mediated binding of BMP-9 to the cell surface but without any signal transduction being initiated. This evidence concerns the gene ACVRL1 and cancer.